[1] |
LIN Yi, WANG Ce, KANG Xun, KANG Zhuang, CHEN Feng, JIANG Bo, LI Wenbin.
Screening recurrent glioblastoma-related genes and analyzing their gene expressions in association with clinicopathological parameters and prognosis
[J]. China Oncology, 2022, 32(1): 13-23.
|
[2] |
LI Zeng , WU Yi , CHEN Zhuzhong , CHEN Li , LIAO Hong , MAO Dun , XIAO Yingming , XIE Hongping , LI Xiuli , YANG Shengke , ZHOU Shukui , ZHONG Lei , LU Hao , CHEN Yongji .
The value of 18 F-PSMA-1007 PET/CT in the early diagnosis and clinical treatment of patients with biochemical recurrence after radical prostatectomy
[J]. China Oncology, 2021, 31(11): 1081-1087.
|
[3] |
LU Xiaoteng, XU Qing.
A study on factors associated with recurrence of non-small cell lung cancer based on CT image features
[J]. China Oncology, 2020, 30(8): 636-640.
|
[4] |
CHEN Yang , LIU Wei , LI Ruimin , WANG Qifeng , SHEN Xigang , TANG Wei .
Radiogenomics: association between BI-RADS mammographic imaging features and the 21-gene recurrence score
[J]. China Oncology, 2020, 30(7): 505-511.
|
[5] |
FENG Zheng, WU Xiaohua.
Hematological toxicities of maintenance PARP inhibitors for patients with platinum-sensitive recurrent ovarian cancer
[J]. China Oncology, 2020, 30(4): 299-304.
|
[6] |
GAO Luying, LIN Yansong, JIANG Yuxin, LI Jianchu, LI Hui, ZHANG Bo, LIU Ruyu, XI Xuehua, GAO Qiong, WANG Ying, ZHAO Ruina.
Evaluation of short-term efficacy of apatinib using cervical ultrasound and thyroglobulin in the treatment of progressive radioactive iodine-refractory differentiated thyroid cancer
[J]. China Oncology, 2019, 29(6): 418-422.
|
[7] |
SUI Huimin, LIU Jierui, WANG Tong, ZHU Zhaohui, LIN Yansong.
Clinicopathological risk factors for distant metastasis of differentiated thyroid carcinoma in children and adolescents
[J]. China Oncology, 2019, 29(6): 423-428.
|
[8] |
LU Chenghui, LI Jiao, LIU Xinfeng, WANG Guoqiang, WANG Zenghua, WANG Xufu.
Clinical outcome after 131I treatment in differentiated thyroid cancer with negative stimulated thyroglobulin and lymph node metastasis
[J]. China Oncology, 2019, 29(6): 429-433.
|
[9] |
LIU Shan, FANG Juan, WANG Lili, ZHANG Yinghong, DU Wenjie, ZHU Taohua.
Association between peripheral nerve invasion and recurrence risk factors in cervical cancer
[J]. China Oncology, 2019, 29(6): 439-444.
|
[10] |
ZHANG Na, LIN Yansong, LIANG Jun.
The clinical significance of thyroglobulin antibody measurement in 131I therapy of differentiated thyroid carcinoma
[J]. China Oncology, 2019, 29(6): 452-456.
|
[11] |
SONG Juanjuan, LIU Yanqing, LIN Yansong.
Clinical analysis of short-term outcome in low-to-intermediate-risk thyroid cancer after low-dose 131I therapy
[J]. China Oncology, 2019, 29(3): 207-211.
|
[12] |
LIU Jierui, LIANG Jun, LIN Yansong.
Relationship between preablative stimulated thyroglobulin and the excellent response in differentiated thyroid carcinoma
[J]. China Oncology, 2019, 29(2): 125-130.
|
[13] |
ZHANG Teng, HU Houyang, BAI Qinghua, et al.
Effect of lymphocytic thyroiditis on response of differentiated thyroid cancer patients after 131I therapy
[J]. China Oncology, 2018, 28(6): 419-423.
|
[14] |
XU Ye, ZHOU Yang, TANG Na, et al.
Value of preoperative magnetic resonance imaging in predicting postoperative recurrence and metastasis of middle rectal cancer
[J]. China Oncology, 2018, 28(5): 376-382.
|
[15] |
XUE Fen, LI Duanshu, HU Chaosu, et al.
Application of intensity-modulated radiotherapy in locoregionally advanced and recurrent poorly differentiated thyroid carcinoma
[J]. China Oncology, 2018, 28(3): 216-221.
|